Plant-Based Foods As a Source of Lipotropes for Human Nutrition: a Survey of in Vivo Studies Anthony Fardet, Jean-Michel Chardigny

Total Page:16

File Type:pdf, Size:1020Kb

Plant-Based Foods As a Source of Lipotropes for Human Nutrition: a Survey of in Vivo Studies Anthony Fardet, Jean-Michel Chardigny Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies Anthony Fardet, Jean-Michel Chardigny To cite this version: Anthony Fardet, Jean-Michel Chardigny. Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies. Critical Reviews in Food Science and Nutrition, Taylor & Francis, 2013, 53 (6), pp.535-590. 10.1080/10408398.2010.549596. hal-02648978 HAL Id: hal-02648978 https://hal.inrae.fr/hal-02648978 Submitted on 29 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Critical Reviews in Food Science and Nutrition For Peer Review Only Plant-Based Foods As a Source of Lipotropes for Human Nutrition: a Survey of In Vivo Studies Journal: Critical Reviews in Food Science and Nutrition Manuscript ID: Draft Manuscript Type: Review Date Submitted by the Version preprint Author: Complete List of Authors: Fardet, Anthony; INRA, Human Nutrition Keywords: Phytochemicals, lipotropes, hepatic steatosis, humans, rats URL: http://mc.manuscriptcentral.com/bfsnComment citer ce document : Email: [email protected] Fardet, A., Chardigny, J.-M. (2013). Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies. Critical Reviews in Food Science and Nutrition, 53 (6), 535-590. DOI : 10.1080/10408398.2010.549596 Page 1 of 267 Critical Reviews in Food Science and Nutrition 1 2 1 Plant-Based Foods As a Source of Lipotropes for Human Nutrition: a Survey of 3 4 5 2 In Vivo Studies 6 7 8 3 9 10 4 ANTHONY FARDET, PhD,a and JEAN-MICHEL CHARDIGNY, PhDa 11 12 5 13 14 15 6 16 For Peer Review Only 17 7 18 19 8 20 21 22 9 23 24 10 25 26 27 11 28 29 12 30 31 13 aINRA, UMR 1019 Nutrition Humaine, F-63122 Saint Genès Champanelle, France ; Clermont 32 33 34 14 Université, UFR Médecine, UMR 1019 Nutrition Humaine, F-63000, Clermont-Ferrand, France ; 35 36 15 CRNH Auvergne, F-63000 Clermont-Ferrand, France. 37 38Version preprint 16 39 40 41 17 42 43 18 Address correspondence to Anthony Fardet, INRA, UMR 1019 Nutrition Humaine, F-63122 Saint 44 45 46 19 Genès Champanelle, France ; Clermont Université, UFR Médecine, UMR 1019 Nutrition Humaine, 47 48 20 F-63000, Clermont-Ferrand, France ; CRNH Auvergne, F-63000 Clermont-Ferrand, France, Tel. 49 50 21 +33(0)4 73 62 47 04, Fax. +33(0)4 73 62 47 55. E-mail: [email protected] 51 52 53 22 54 55 23 56 57 24 58 59 60 25 26 1 URL: http://mc.manuscriptcentral.com/bfsnComment citer ce document : Email: [email protected] Fardet, A., Chardigny, J.-M. (2013). Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies. Critical Reviews in Food Science and Nutrition, 53 (6), 535-590. DOI : 10.1080/10408398.2010.549596 Critical Reviews in Food Science and Nutrition Page 2 of 267 1 2 1 Abstract 3 4 5 2 Increased consumption of plant products is associated with lower chronic disease prevalence. This 6 7 3 is attributed to the great diversity of their phytochemicals and to their numerous positive 8 9 4 physiological effects. The most investigated have been their antioxidant, anti-carcinogenic, 10 11 12 5 hypolipidemic and hypoglycemic properties. Yet, some compounds have been very early shown to 13 14 6 be lipotropic in animals. This property is defined as the capacity of a compound to hasten the 15 16 7 removal of fat fromFor liver and/orPeer to reduce Review hepatic lipid synthesis Only through several mechanisms, 17 18 19 8 mainly involving increased phospholipid synthesis via the transmethylation pathway for 20 21 9 triglyceride-rich lipoprotein exportation from liver, increased fatty acid β-oxidation and/or down- 22 23 10 and up-regulation of genes involved in respectively lipogenic and fatty acid oxidation enzyme 24 25 26 11 synthesis. Main plant lipotropes are choline, betaine, myo-inositol, methionine and carnitine. 27 28 12 Magnesium, niacin, pantothenate and folates also indirectly support the overall lipotropic effect. 29 30 31 13 The exhaustive reviewing of animal studies investigating the effect of phytochemicals on hepatic 32 33 14 lipid metabolism suggest that some unsaturated fatty acids, acetic acid, melatonin, phytic acid, some 34 35 15 fiber, oligofructose, flavonoids, lignans, stilbenes, curcumin and saponins may be also considered 36 37 38Version preprint 16 as having lipotropic effects. However, this will have to be confirmed in humans for which 39 40 17 intervention studies are practically non-existent. 41 42 18 43 44 45 19 Keywords: Phytochemicals, lipotrope, hepatic steatosis, humans, rats 46 47 20 48 49 21 50 51 52 22 53 54 23 55 56 57 24 58 59 25 60 26 2 URL: http://mc.manuscriptcentral.com/bfsnComment citer ce document : Email: [email protected] Fardet, A., Chardigny, J.-M. (2013). Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies. Critical Reviews in Food Science and Nutrition, 53 (6), 535-590. DOI : 10.1080/10408398.2010.549596 Page 3 of 267 Critical Reviews in Food Science and Nutrition 1 2 1 PLANT-BASED FOOD CONSUMPTION, CHRONIC DISEASE RISK AND 3 4 5 2 PHYTOCHEMICALS 6 7 8 3 Epidemiological and observational studies 9 10 4 Increased consumption of plant-based foods (PBF), mainly whole-grain cereals, legumes, 11 12 5 vegetables and fruits, is generally associated with a lower prevalence of all-cause mortality and of 13 14 15 6 the major chronic diseases that are cardiovascular diseases (CVD), obesity, diabetes and cancers. 16 For Peer Review Only 17 7 However, more specifically, the effects seem to vary according to the botanical origin of the PBF 18 19 8 with more or less conclusive results from prospective studies. Thus, while whole-grain cereals have 20 21 22 9 been convincingly shown to be protective against all main chronic diseases or disorders (Chan et 23 24 10 al., 2007; Chatenoud et al., 1998; De Munter et al., 2007; Flight and Clifton, 2006; Jacobs et al., 25 26 27 11 2007; Jacobs et al., 1998; Koh-Banerjee et al., 2004; Koh-Banerjee and Rimm, 2003; Larsson et al., 28 29 12 2005; Mellen et al., 2008; Murtaugh et al., 2007; Sahyoun et al., 2006; Schatzkin et al., 2008; Van 30 31 13 De Vijver et al., 2009; Venn and Mann, 2004; Williams et al., 2008), the effects of legumes, fruits 32 33 34 14 and/or vegetables are less obvious with both either no or positive effects reported that depends on 35 36 15 the variety used, the population studied, the targeted disease or the age of the subjects. For example, 37 Version preprint 38 16 the protective role of PBF and plant-based diets against childhood obesity has been recently 39 40 41 17 reviewed: it clearly appears that, except for ready-to-eat cereals, there is a lack of evidence to 42 43 18 conclude for an association between PBF and childhood obesity in relation with fruit and vegetable, 44 45 46 19 grain other than cereal, and legume intake (Newby, 2009). 47 48 20 To summarize, the most conclusive associations are observed with whole-grain cereals for 49 50 21 all diseases, with legumes on mortality risk (all-cause, CVD or cancers) (Nagura et al., 2009; 51 52 53 22 Noethlings et al., 2008), with fruits on CVD (Hung et al., 2004; Nagura et al., 2009) and weight 54 55 23 gain/obesity (Buijsse et al., 2009; He et al., 2004), with vegetables on CVD (Hung et al., 2004; 56 57 24 Nagura et al., 2009), weight gain/obesity (Buijsse et al., 2009; He et al., 2004) and type 2 diabetes 58 59 60 25 (Bazzano et al., 2008; Villegas et al., 2008), and with both fruits and vegetables on all-cause 26 mortality (Rissanen et al., 2003; Steffen et al., 2003) and cancers (Pavia et al., 2006; Van 3 URL: http://mc.manuscriptcentral.com/bfsnComment citer ce document : Email: [email protected] Fardet, A., Chardigny, J.-M. (2013). Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies. Critical Reviews in Food Science and Nutrition, 53 (6), 535-590. DOI : 10.1080/10408398.2010.549596 Critical Reviews in Food Science and Nutrition Page 4 of 267 1 2 1 Duijnhoven et al., 2009) (Table 1). Moreover, some authors have observed a significant association 3 4 5 2 between diseases risk and mortality with specific vegetable or fruit sub-family consumption such as 6 7 3 cruciferous, Alliaceae, green leafy and yellow-orange vegetables, root vegetables, citrus or fruit- 8 9 4 berry. This is underlined for cancer (Kolonel et al., 2000; Wu et al., 2009), diabetes (Bazzano et al., 10 11 12 5 2008), cerebrovascular disease (Mizrahi et al., 2009) and all-cause mortality (Nagura et al., 2009; 13 14 6 Noethlings et al., 2008) risks. More specifically, the inverse association between green tea 15 16 7 consumption and Forpsychological Peer distress in Reviewa Japanese cohort has Onlybeen recently reported (Hozawa et 17 18 19 8 al., 2009).
Recommended publications
  • The Role of Nutritional Therapies in the Care Of
    © Michael Ash BSc DO ND F.DipION 2010 4/29/2010 'The role of Nutritional Therapy in the care of individuals with cardiovascular related problems' Michael Ash BSc (Hons) DO ND F DipION mBANT NTCC Osteopath Naturopath Nutritional Therapist Researcher Author Nutritional Therapy • A Functional Medicine approach to optimise outcomes, ease of engagement and compliance. • 8 Practical strategies & how to avoid common pitfalls. • Interaction of the immune system with the heart. • GastroCentric Perspective. • How food selection can provide a multi faceted benefit. • Supplements of benefit. 1 © Michael Ash BSc DO ND F.DipION 2010 4/29/2010 Client Overview Goals Determine their aims and outcomes – the purpose of the plan is to support the patients goals with evidence based strategies Identify realistic goals, obtain agreement that these are achievable and describe plan ASSESMENT ANTECEDENTS TRIGGERS Medical history review and systems analysis assess the: MEDIATORS Antecedents: Sex, Age, Genetics, Lifestyle, Experiences, Trauma, Childhood, Stress, etc. Triggers: Events that initiate illness or symptoms – stress, infection, environmental toxins, food. etc. – look to see if they can be removed or controlled Mediators: Cytokines, prostaglandins, free radicals, neurotransmitters, fear, personal value, behavioural conditioning, poverty, etc. Evolutionary Nutritional Therapy • In physiology, foetal nutritional stress appears to flip an evolved switch that sets the body into a state that protects against starvation. • When these individuals encounter modern diets, they respond with the deadly metabolic syndrome of obesity, hypertension, and diabetes. • Barker DJ, Eriksson JG, Forsén T, Osmond C.Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002 Dec;31(6):1235-9.
    [Show full text]
  • The Effect of Vitamin Supplementation on Subclinical
    molecules Review The Effect of Vitamin Supplementation on Subclinical Atherosclerosis in Patients without Manifest Cardiovascular Diseases: Never-ending Hope or Underestimated Effect? Ovidiu Mitu 1,2,* , Ioana Alexandra Cirneala 1,*, Andrada Ioana Lupsan 3, Mircea Iurciuc 4 , 5 5 2, Ivona Mitu , Daniela Cristina Dimitriu , Alexandru Dan Costache y , Antoniu Octavian Petris 1,2 and Irina Iuliana Costache 1,2 1 Department of Cardiology, Clinical Emergency Hospital “Sf. Spiridon”, 700111 Iasi, Romania 2 1st Medical Department, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania 3 Department of Cardiology, University of Medicine, Pharmacy, Science and Technology, 540139 Targu Mures, Romania 4 Department of Cardiology, University of Medicine and Pharmacy “Victor Babes”, 300041 Timisoara, Romania 5 2nd Morpho-Functional Department, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania * Correspondence: [email protected] (O.M.); [email protected] (I.A.C.); Tel.: +40-745-279-714 (O.M.) Medical Student, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania. y Academic Editors: Raluca Maria Pop, Ada Popolo and Stefan Cristian Vesa Received: 25 March 2020; Accepted: 7 April 2020; Published: 9 April 2020 Abstract: Micronutrients, especially vitamins, play an important role in the evolution of cardiovascular diseases (CVD). It has been speculated that additional intake of vitamins may reduce the CVD burden by acting on the inflammatory and oxidative response starting from early stages of atherosclerosis, when the vascular impairment might still be reversible or, at least, slowed down. The current review assesses the role of major vitamins on subclinical atherosclerosis process and the potential clinical implications in patients without CVD.
    [Show full text]
  • The Efficacy of Pantothenic Acid As a Modifier of Body Composition in a Porcine Model of Obesity Development
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1-1-2004 The efficacy of pantothenic acid as a modifier of body composition in a porcine model of obesity development Carey Ann Baldwin Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Recommended Citation Baldwin, Carey Ann, "The efficacy of pantothenic acid as a modifier of body composition in a porcine model of obesity development" (2004). Retrospective Theses and Dissertations. 20349. https://lib.dr.iastate.edu/rtd/20349 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. The efficacy of pantothenic acid as a modifier of body composition in a porcine model of obesity development by Carey Ann Baldwin A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Animal Nutrition Program of Study Committee: Tim Stahly, Major Professor Paul Flakoll Chad Stahl Iowa State University Ames, Iowa 2004 Copyright© Carey Ann Baldwin, 2004. All rights reserved. 11 Graduate College Iowa State University This is to certify that the master's thesis of Carey Ann Baldwin has met the thesis requirements of Iowa State University Signatures have been redacted for privacy 111 TABLE OF CONTENTS ACKNOWLEDGEMENTS Vl ABSTRACT Vll CHAPTER 1. GENERAL INTRODUCTION 1 Introduction 1 Thesis Organization 2 Literature Cited 2 CHAPTER 2.
    [Show full text]
  • WCA Clinical Nutrition Module 1 Part 2
    Chiropractic Nutrition Module 1 Part 2 of 2 By: Chad Oler, ND WCA Clinical Nutrition: Module 1 Chad Oler, ND Chad Oler, ND ° Micronutrients ° Water soluble vitamins: RDAs, deficiency, toxicity ° Fat Soluble vitamins: RDAs, deficiency, toxicity ° Minerals: RDAs, deficiency, toxicity ° Metals: RDAs, deficiency, toxicity ° Phytonutrients ° Non-essential and conditionally essential nutrients ° Efficacy, safety, risks and benefits of glandular products and therapeutic enzymes ° Micronutrients ° Vitamins ▪ Water soluble – B, C ▪ Fat soluble – A, E, D, K ° Minerals ° Antioxidants ° Phytonutrients ° Amino acids ° Conditionally Essential Nutrients www.naturalpathhealthcenter.com 1 WCA Clinical Nutrition: Module 1 Chad Oler, ND ° Cannot be synthesized in sufficient quantities and must be obtained through diet ° Classified by their biological and chemical activity, not their structure ° Each “vitamin” refers to a number of vitamer compounds that all show the biological activity associated with a particular vitamin ° Each set of compounds is grouped under an alphabetized vitamin “generic descriptor” title ▪ “Vitamin A” includes retinal, retinol, and four known carotenoids. ° Vitamers by definition are convertible to the active form of the vitamin in the body and are sometimes inter- convertible to one another as well www.naturalpathhealthcenter.com 2 WCA Clinical Nutrition: Module 1 Chad Oler, ND ° Vitamin B1 –Thiamin ° Vitamin B2 – Riboflavin ° Vitamin B3 – Niacin ° Vitamin B5 – Pantothenic Acid ° Vitamin B6 – Pyridoxine ° Vitamin B7 - Biotin °
    [Show full text]
  • Compositions Comprising Nebivolol
    (19) TZZ ZZ__T (11) EP 2 808 015 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 03.12.2014 Bulletin 2014/49 A61K 31/34 (2006.01) A61K 31/502 (2006.01) A61K 31/353 (2006.01) A61P 9/00 (2006.01) (21) Application number: 14002458.9 (22) Date of filing: 16.11.2005 (84) Designated Contracting States: • O’Donnell, John AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Morgantown, WV 26505 (US) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Bottini, Peter Bruce SK TR Morgantown, WV 26505 (US) • Mason, Preston (30) Priority: 31.05.2005 US 141235 Morgantown, WV 26504 (US) 10.11.2005 US 272562 • Shaw, Andrew Preston 15.11.2005 US 273992 Morgantown, WV 26504 (US) (62) Document number(s) of the earlier application(s) in (74) Representative: Samson & Partner accordance with Art. 76 EPC: Widenmayerstraße 5 09015249.7 / 2 174 658 80538 München (DE) 05848185.4 / 1 890 691 Remarks: (71) Applicant: MYLAN LABORATORIES, INC This application was filed on 16-07-2014 as a Morgantown, NV 26504 (US) divisional application to the application mentioned under INID code 62. (72) Inventors: • Davis, Eric Morgantown, WV 26508 (US) (54) Compositions comprising nebivolol (57) The active ingredients of the pharmaceutical composition described consist of nebivolol, one or more ACE inhibitors and one or more ARB. EP 2 808 015 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 808 015 A1 Description [0001] This application is a continuation-in-part of application Ser.
    [Show full text]
  • Growth of Bifidobacteria in Adults' Intestines on Oral Administration of Sugar Source, Pantethine and Riboflavin
    Bifidobacteria Microflora Vol. 3(1), 43-49, 1984 ORIGINAL Growth of Bifidobacteria in Adults' Intestines on Oral Administration of Sugar Source, Pantethine and Riboflavin Kouhei YAZAWA,1* Akiko NAKAJIMA1 and Zenzo TAMURA2 Department of Analytical Chemistry,Faculty of PharmaceuticalSciences , Universityof Tokyo, Hongo, Bunkyo-ku, Tokyo 113,1 and Keio UniversityHospital Pharmacy, Shinanomachi,Shinjuku-ku, Tokyo 1602 (Received 24 December, 1983) Among 45 Bifidobacteriumstrains of adult origin , all required a sugar source (ex. lactose) and pantethine (or pantothenic acid), 35 strains required riboflavin , and 12 required thiamine as essential nutrients . Fifteen strains were able to grow on pantothenic acid as well as pantethine. Fewer than 9 strains required other nutrients. The sugar source (10 to 15 g/day), pantethine (50 mg/day) and riboflavin (5 mg/day) were orally administered to 2 healthy adults whose proportion of bifidobacteria in the intestinal florae was usually very low (less than 1% of total bacterial number) . The sugar source was lactulose, raffinose or inulin. Pantethine and riboflavin were packed together in capsules and enteric-coated. Administration of both sugar source and vitamin capsules caused marked growth of bifidobacteria (more than 40% of total bacterial number) in both adults. Administration of the sugar source alone caused moderate growth of bifidobacteria (13%), while administration of the vitamin capsules alone was ineffective. These results indicate that the sugar source is es- sential for growth of bifidobacteria in adults, as well as in infants, and that adminis- tration of pantethine and riboflavin is important. Key words: Nutritional requirement; pantethine; riboflavin; sugar source; Bifi- dobacterium;lactulose; raffinose, inulin A great deal of investigation has been source in bottle-fed infants.
    [Show full text]
  • Vitamins and Minerals: a Brief Guide
    Vitamins and minerals: a brief guide A Sight and Life publication Vitamins and minerals: a brief guide Vitamins are organic nutrients that are essential for life. Our bodies need vitamins to function properly. We cannot produce most vitamins ourselves, at least not in sufficient quantities to meet our needs. Therefore, they have to be obtained through the food we eat. What are vitamins A mineral is an element that originates in the Earth and always retains its chemical identity. Minerals occur as inorganic crystalline salts. Once minerals enter the body, they remain there until and minerals? excreted. They cannot be changed into anything else. Minerals cannot be destroyed by heat, air, acid, or mixing. Compared to other nutrients such as protein, carbohydrates and fat, vitamins and minerals are present in food in tiny quantities. This is why vitamins and minerals are called micronutrients, because we consume them only in small amounts. Each of the vitamins and minerals known today has specific functions in the body, which makes them unique and irreplaceable. No single food contains the full range of vitamins and minerals, and inadequate nutrient intake results in deficiencies. A variety of foods is therefore vital to meet the body’s vitamin and mineral requirements. Of the known vitamins, four are fat-soluble. This means that fat or oil must be consumed for the vitamins to be absorbed by the body. These fat-soluble vitamins are A, D, E and K. The others are water-soluble: these are vitamin C and the B-complex, consisting of vitamins B1, B2, B6, B12, niacin, folic acid, biotin, pantothenic acid and choline.
    [Show full text]
  • The Truth About B-Vitamins
    THE TRUTH ABOUT B-VITAMINS EXPLORING A COMPLEX TOPIC FUNCTIONS SOURCES DEFICIENCIES THE TRUTH SERIES THE TRUTH SERIES As a discerning user of natural health products, you want what is best for your health. However, misinformation and deceptive marketing often make it challenging to TABLE OF CONTENTS identify fact from fiction. The Truth Series was created by Advanced Orthomolecular Research (AOR) to share the evidence-based truth about the most controversial and confusing topics within the natural health industry. At AOR, we believe that truth and transparency are the most important values for any organization to uphold. As visionaries, we are committed to continuous innovation so that we can advance the world of natural health. As such, the Truth Series aligns with our vision of providing optimal products without compromise. Published in Canada by: Advanced Orthomolecular Research Inc. Making Sense of B Vitamins 5 Managing Editor: Randall Heilik Vitamin B Deficiencies — Signs and Causes 12 Associate Editor: Justine Cooke Authors: Randall Heilik, CHNC, BCoMS, Scientific Consultant The Vital Role Vitamin B Plays in our Life Story 24 Dr. Navnirat Nibber ND, BSc, AOR Medical Advisor Dr. Aaron Zadek B.Sc. ND, Medical Advisor De-Mystifying Methylation 30 Dr. Robyn Murphy BSc, ND, Clinical Research Advisor B Vitamins: Myths and Controversies 40 Dr. Sarah Zadek, BSc. ND, Clinical Research Advisor Dr. Paul Hrkal, B.Kin ND, AOR Medical Director Nutrient spotlight: Pyrroloquinoline Quinone (PQQ) 48 Publication Design / Art Production: Laura Mensinga Creative Direction: Pix-l Graphx How to Get the B’s You Need 52 DISCLAIMER: The information in this publication is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment.
    [Show full text]
  • Establishing Tolerable Upper Intake Levels and a Risk Assessment
    Report of the Scientific Committee of the Food Safety Authority of Ireland The Safety of Vitamins and Minerals in Food Supplements – Establishing Tolerable Upper Intake Levels and a Risk Assessment Approach for Products Marketed in Ireland (Revision 2) Report of the Scientific Committee of the Food Safety Authority of Ireland The Safety of Vitamins and Minerals in Food Supplements – Establishing Tolerable Upper Intake Levels and a Risk Assessment Approach for Products Marketed in Ireland Published by: Food Safety Authority of Ireland Email: [email protected] Website: www.fsai.ie Join us on LinkedIn Follow us on Twitter @FSAIinfo Say hi on Facebook Visit us on Instagram Subscribe to our Youtube channel Originally published in 2018 Revision published in 2020 Applications for reproduction should be made to the FSAI Information Unit ISBN 978-1-910348-10-9 Report of the Scientific Committee of the Food Safety Authority of Ireland The Safety of Vitamins and Minerals in Food Supplements – Establishing Tolerable Upper Intake Levels and a Risk Assessment Approach for Products Marketed in Ireland CONTENTS ABBREVIATIONS 5 FOREWORD 6 EXECUTIVE SUMMARY 7 Recommendations ......................................................8 1. SAFETY OF VITAMINS AND MINERALS IN FOOD SUPPLEMENTS 11 1.1 Purpose of this Report . 11 1.2 Micronutrients ....................................................11 1.3 Vitamins . 11 1.4 Minerals and Trace Elements . 12 1.5 Dietary Reference Values ..........................................12 1.6 Sources of Intake..................................................16 1.7 Dietary Intakes in Ireland ..........................................17 1.8 Vitamins and Minerals: Relevant Food Legislation in Ireland . 20 1.9 Issues Arising Due to the Absence of Maximum Limits for Vitamins and Minerals added to Foods and used in Food Supplements .
    [Show full text]
  • Lessons Learned
    Prevention and Reversal of Chronic Disease Copyright © 2019 RN Kostoff PREVENTION AND REVERSAL OF CHRONIC DISEASE: LESSONS LEARNED By Ronald N. Kostoff, Ph.D., School of Public Policy, Georgia Institute of Technology 13500 Tallyrand Way, Gainesville, VA, 20155 [email protected] KEYWORDS Chronic disease prevention; chronic disease reversal; chronic kidney disease; Alzheimer’s Disease; peripheral neuropathy; peripheral arterial disease; contributing factors; treatments; biomarkers; literature-based discovery; text mining ABSTRACT For a decade, our research group has been developing protocols to prevent and reverse chronic diseases. The present monograph outlines the lessons we have learned from both conducting the studies and identifying common patterns in the results. The main product of our studies is a five-step treatment protocol to reverse any chronic disease, based on the following systemic medical principle: at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective. Implementation of the five-step treatment protocol is as follows: FIVE-STEP TREATMENT PROTOCOL TO REVERSE ANY CHRONIC DISEASE Step 1: Obtain a detailed medical and habit/exposure history from the patient. Step 2: Administer written and clinical performance and behavioral tests to assess the severity of symptoms and performance measures. Step 3: Administer laboratory tests (blood, urine, imaging, etc) Step 4: Eliminate ongoing contributing factors to the chronic disease Step 5: Implement treatments for the chronic disease This individually-tailored chronic disease treatment protocol can be implemented with the data available in the biomedical literature now. It is general and applicable to any chronic disease that has an associated substantial research literature (with the possible exceptions of individuals with strong genetic predispositions to the disease in question or who have suffered irreversible damage from the disease).
    [Show full text]
  • Why Supracaps?
    Why SupraCaps? FORMULA ! QUALITY ! CONVENIENCE ! VALUE FORMULA — 45 High Quality Ingredients, including: 18 Vitamins 11 Minerals 10 Fruit & Herb Extracts Alpha-Lipoic Acid CoQ10 Lutein Lycopene Quercetin Vinpocetine QUALITY All Ingredients at Meaningful Potencies Organic Mineral Chelates (not inorganic mineral salts) Standardized Fruit & Herb Extracts FDA registered and GMP Certified Facility (NSF International) CONVENIENCE Replaces Many Bottles of Supplements VALUE Save at Least 50% over Buying Supplements Separately The SupraCaps Formula VITAMINS. 7 CAPS 14 CAPS Vitamin A (vitamin A palmitate). 2,500 IU 5,000 IU Vitamin A (natural carotenes: alpha, beta, cryptoxanthin, zeaxanthin, and lutein). 5,000 IU 10,000 IU Vitamin D3 (cholecalciferol). 1,000 IU 2,000 IU Vitamin E (d-alpha tocopheryl succinate plus d-beta, d-delta, d-gamma tocopherols). 100 IU 200 IU Vitamin K (phytonadione and menaquinone-7). 60 mcg 120 mcg Vitamin C (ascorbic acid).. 500 mg 1,000 mg Vitamin B1 (thiamin HCl). 25 mg 50 mg Vitamin B2 (riboflavin). 25 mg 50 mg Vitamin B3 (niacin). 19 mg 38 mg Vitamin B3 (niacinamide). 56 mg 112 mg Vitamin B5 (d-calcium pantothenate). 50 mg 100 mg Vitamin B6 (pyridoxine HCl).. 25 mg 50 mg Vitamin B12 (methylcobalamin). 200 mcg 400 mcg Biotin. 300 mcg 600 mcg Folate (L-5-methyltetrahydrofolate).. 400 mcg 800 mcg Choline (bitartrate). 100 mg 200 mg Inositol. 100 mg 200 mg PABA (para-aminobenzoic acid). 25 mg 50 mg MINERALS Boron (aspartate-citrate).. 1 mg 2 mg Calcium (citrate-malate).. 200 mg 400 mg Chromium (nicotinate glycinate chelate). 100 mcg 200 mcg Copper (bisglycinate chelate).
    [Show full text]
  • Subject Index to Abstracts
    003 1-3998/85/1904-44 lA$02.00 Vol. 19, No. 4, 1985 PEDIATRIC RESEARCH Printed in U.S.A. Copyright O 1985 International Pediatric Research Foundation,Inc. SUBJECT INDEX TO ABSTRACTS 1,25 (OH)2 D 1200 ADENOSINE DEAMINASE 909, 962, ALCOHOLISM 514 1,25 DIHYDROXYVITAMIN D3 973 967 ALDOSTERONE 333, 334, 808, 1,251 DIHYDROXYVITAMIN D 1223, ADENOSINE TRIPHOSPHATASE 323, 1591, 1605 1681 1571 ALKALINE PHOSPHATASE 728, 1200 14C DEOXYGLUCOSE 1316 ADENOSINE TRIPHOSPHATE 90, 98, ALKALOSIS 796 17 HYDROXYPROGESTERONE 436 860, 1600 ALKALOSIS, RESPIRATORY 1409 21 HYDROXYLASE DEFICIENCY 861 ADENOTONSILLECTOMY 1725 ALLERGY 652 21 HYDROXYLASE DEFICIENCY, ADENOVIRUS INFECTIONS 950 ALLOGENEIC 1018 NONCLASSICAL 861 ADENOVIRUSES, HUMAN 585 ALLOGRAFT REJECTION 1647 24 HOUR 440 ADENYL CYCLASE 277, 439, 1592 ALLOGRAFTS 1593, 1593 24 HYDROXYLASE RESPONSE 1200 ADHERENCE 880 ALMITRINE 837 25 (OH) D 1200 ADHESION 309 ALOPECIA 973 25 HYDROXYVITAMIN D 1 HYDROXYLASE ADHESIVE GLYCOPROTEINS 880 ALPHA 1-ANTITRYPSIN 1822 1223 ADIPOCYTE 713 ALPHA 1-ANTITRYPSIN DEFICIENCY 2H (OH) D 1200 ADIPOSE TISSUE 1187 813 3 BETAHYDROXYSTEROID ADIPOSITY 713 ALPHA FETOPROTEINS 1296, 1305 DEHYDROGENASE 431 ADOLESCENT BEHAVIOR 10, 19 ALPHA MANNOSIDASE 1241 3 METHYLGLUTACONIC ACID 823 ADOLESCENT PREGNANCY 20 ALPHA TOCOPHEROL 1466 3 METHYLGLUTACONIC ACIDURIA 823 ADRENAL 275, 334 ALTERNATE DAY STEROIDS 1726 3 METHYLGLUTARIC ACID 823 ADRENAL ANDROGEN SECRETION 480 ALTITUDE 273 4 CHANNEL PNEUMOGRAM 1523 ADRENAL CORTICOSTEROIDS 454 ALUMINUM 1595 5' NUCLEOTIDASE 881 ADRENAL HYPERPLASIA 431, 467 ALUMINUM
    [Show full text]